GeoVax (GOVX) Accelerates Development of GEO-MVA Vaccine Amid Expanding Global Mpox Crisis and Reaffirmed...
EMA Scientific Guidance, Global Surge in Clade I Mpox, and Aid Shortfalls Drive Urgent Need for Scalable, Equitable Vaccine Solutions
LIVE QUOTE
ATLANTA, GA - July...
TWO DOUBLES, From the Same Stock! Bavarian Nordic (BVRNY) $12.25, gains 149% After Adding...
Been quite sometime since we had Watch List company taken out, at over $1 Billion but here we go again. With our 4th billion...
GeoVax (GOVX) Comments on HHS mRNA Vaccine Rollback: Urges Full Embrace of MVA-Based Multi-Antigen...
https://youtu.be/4LffUyg6yE8?si=G8_kZMce8yHGCxKp
GEO-CM04S1 Offers Solution to Overcome HHS-Cited mRNA Deficiencies - Potentially Offering Broader, More Durable Protection
ATLANTA, GA - August 7, 2025 (NEWMEDIAWIRE) - GeoVax Labs,...
Happy News! GSK (GSK) Just Paid $367 Million, for Synvidia’s Pre-Clinical Trial Cancer Treatment.
One of the Fun Features of Biotech Investing, is Getting Paid on a Treatment That Hasn't Even Entered Clinical Trials.
A lot of investors...
GeoVax (GOVX) Reports Both Favorable Safety and “It’s Working” News for its Cancer...
Official Headline is "GeoVax Announces JCO Oncology Advances Publication Highlighting Favorable Safety and Evidence of Disease Stability of Gedeptin(R) in Recurrent Head & Neck...
Latest article
Fairchild Gold Corp., Presenting at Palm Beach Investor Roadshow.
Vancouver, British Columbia and Las Vegas, Nevada--(Institutional Analyst - April 8th, 2026) - Fairchild Gold Corp. (TSXV: FAIR) (FSE: Y4Y) (OTCQB: FCHDF) ("Fairchild" or the "Company"),...
Precious Metals Analyst | Mark Reichman | Noble Capital
Mark Reichman
Senior Research Analyst, Industrials and Basic Industries
BIO
Mark joined Noble as a senior research analyst with coverage responsibility in the Industrials and Basic Industries...
